HK Stock MarketDetailed Quotes

PA GOODDOCTOR (01833)

Watchlist
  • 10.750
  • -0.100-0.92%
Market Closed Apr 30 16:08 CST
23.24BMarket Cap48.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PA GOODDOCTOR (01833) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
Turnover
9.06%1.16B
13.73%5.47B
--3.72B
19.52%2.5B
--1.06B
2.88%4.81B
-5.79%2.09B
-24.68%4.67B
-21.50%2.22B
-15.40%6.21B
Operating income
13.73%5.47B
19.52%2.5B
2.88%4.81B
-5.79%2.09B
-24.68%4.67B
-21.50%2.22B
-15.40%6.21B
Cost of sales
----
-12.52%-3.7B
----
-17.11%-1.66B
----
-3.78%-3.28B
5.78%-1.42B
30.19%-3.17B
27.53%-1.51B
19.43%-4.53B
Operating expenses
-12.52%-3.7B
-17.11%-1.66B
-3.78%-3.28B
5.78%-1.42B
30.19%-3.17B
27.53%-1.51B
19.43%-4.53B
Gross profit
16.34%1.77B
24.62%839.71M
0.98%1.52B
-5.81%673.8M
-9.74%1.51B
-4.83%715.36M
-2.09%1.67B
Selling expenses
----
-8.57%-828.92M
----
-3.90%-381.02M
----
8.65%-763.51M
18.57%-366.72M
25.40%-835.8M
16.57%-450.35M
36.23%-1.12B
Administrative expenses
----
9.06%-845.75M
----
5.74%-371.95M
----
37.20%-929.98M
47.85%-394.61M
15.30%-1.48B
15.25%-756.67M
5.31%-1.75B
Special items of operating profit
----
114.68%174.04M
----
-125.80%-11.87M
----
-65.19%81.07M
-65.80%46.02M
-50.57%232.91M
-25.72%134.57M
86.31%471.18M
Operating profit
405.00%271.64M
280.34%74.87M
84.52%-89.06M
88.37%-41.52M
20.80%-575.26M
28.57%-357.09M
55.80%-726.34M
Financing income
----
-41.67%106.48M
----
-41.39%60.03M
----
-26.98%182.56M
-14.12%102.44M
49.17%250M
49.37%119.29M
-1.11%167.59M
Financing cost
----
----
----
----
----
----
----
38.04%-6.89M
22.99%-4.04M
-2.61%-11.11M
Share of profits of associates
----
851.25%2.65M
----
607.09%1.36M
----
11.16%279K
88.90%-268K
100.38%251K
93.13%-2.42M
-71.05%-66.32M
Earning before tax
306.06%380.77M
124.66%136.26M
128.25%93.77M
124.83%60.65M
47.83%-331.89M
46.95%-244.26M
58.24%-636.18M
Tax
----
48.22%-2.82M
----
-5,778.26%-1.35M
----
-83.81%-5.45M
96.19%-23K
13.05%-2.97M
82.93%-604K
78.41%-3.41M
After-tax profit from continuing operations
327.92%377.95M
122.51%134.91M
126.38%88.32M
124.76%60.63M
47.65%-334.86M
47.22%-244.87M
58.45%-639.59M
Earning after tax
138.38%79.11M
327.92%377.95M
183.84M
122.51%134.91M
33.19M
126.38%88.32M
124.76%60.63M
47.65%-334.86M
47.22%-244.87M
58.45%-639.59M
Minority profit
----
-122.63%-1.56M
----
-81.31%744K
----
156.21%6.89M
1,698.80%3.98M
-246.93%-12.26M
83.24%-249K
-190.71%-3.54M
Profit attributable to shareholders
366.07%379.51M
136.84%134.16M
125.24%81.43M
123.16%56.65M
49.28%-322.59M
47.10%-244.62M
58.65%-636.06M
Basic earnings per share
125.00%0.18
40.00%0.07
126.67%0.08
121.74%0.05
49.15%-0.3
46.51%-0.23
57.55%-0.59
Diluted earnings per share
157.14%0.18
40.00%0.07
123.33%0.07
121.74%0.05
49.15%-0.3
46.51%-0.23
57.55%-0.59
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
--
--
PwC
--
PwC
--
PwC
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022
Turnover 9.06%1.16B13.73%5.47B--3.72B19.52%2.5B--1.06B2.88%4.81B-5.79%2.09B-24.68%4.67B-21.50%2.22B-15.40%6.21B
Operating income 13.73%5.47B19.52%2.5B2.88%4.81B-5.79%2.09B-24.68%4.67B-21.50%2.22B-15.40%6.21B
Cost of sales -----12.52%-3.7B-----17.11%-1.66B-----3.78%-3.28B5.78%-1.42B30.19%-3.17B27.53%-1.51B19.43%-4.53B
Operating expenses -12.52%-3.7B-17.11%-1.66B-3.78%-3.28B5.78%-1.42B30.19%-3.17B27.53%-1.51B19.43%-4.53B
Gross profit 16.34%1.77B24.62%839.71M0.98%1.52B-5.81%673.8M-9.74%1.51B-4.83%715.36M-2.09%1.67B
Selling expenses -----8.57%-828.92M-----3.90%-381.02M----8.65%-763.51M18.57%-366.72M25.40%-835.8M16.57%-450.35M36.23%-1.12B
Administrative expenses ----9.06%-845.75M----5.74%-371.95M----37.20%-929.98M47.85%-394.61M15.30%-1.48B15.25%-756.67M5.31%-1.75B
Special items of operating profit ----114.68%174.04M-----125.80%-11.87M-----65.19%81.07M-65.80%46.02M-50.57%232.91M-25.72%134.57M86.31%471.18M
Operating profit 405.00%271.64M280.34%74.87M84.52%-89.06M88.37%-41.52M20.80%-575.26M28.57%-357.09M55.80%-726.34M
Financing income -----41.67%106.48M-----41.39%60.03M-----26.98%182.56M-14.12%102.44M49.17%250M49.37%119.29M-1.11%167.59M
Financing cost ----------------------------38.04%-6.89M22.99%-4.04M-2.61%-11.11M
Share of profits of associates ----851.25%2.65M----607.09%1.36M----11.16%279K88.90%-268K100.38%251K93.13%-2.42M-71.05%-66.32M
Earning before tax 306.06%380.77M124.66%136.26M128.25%93.77M124.83%60.65M47.83%-331.89M46.95%-244.26M58.24%-636.18M
Tax ----48.22%-2.82M-----5,778.26%-1.35M-----83.81%-5.45M96.19%-23K13.05%-2.97M82.93%-604K78.41%-3.41M
After-tax profit from continuing operations 327.92%377.95M122.51%134.91M126.38%88.32M124.76%60.63M47.65%-334.86M47.22%-244.87M58.45%-639.59M
Earning after tax 138.38%79.11M327.92%377.95M183.84M122.51%134.91M33.19M126.38%88.32M124.76%60.63M47.65%-334.86M47.22%-244.87M58.45%-639.59M
Minority profit -----122.63%-1.56M-----81.31%744K----156.21%6.89M1,698.80%3.98M-246.93%-12.26M83.24%-249K-190.71%-3.54M
Profit attributable to shareholders 366.07%379.51M136.84%134.16M125.24%81.43M123.16%56.65M49.28%-322.59M47.10%-244.62M58.65%-636.06M
Basic earnings per share 125.00%0.1840.00%0.07126.67%0.08121.74%0.0549.15%-0.346.51%-0.2357.55%-0.59
Diluted earnings per share 157.14%0.1840.00%0.07123.33%0.07121.74%0.0549.15%-0.346.51%-0.2357.55%-0.59
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young------PwC--PwC--PwC

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -